Actionable data for marijuana business owners
Amid declining medical cannabis sales in Canada’s domestic market and cutthroat competition in the adult-use industry, some licensed producers are increasingly looking to overseas markets for a financial lifeline.
Multistate operators are busy expanding their retail footprints in Florida’s nearly $2 billion medical marijuana market, in some cases betting that adult-use legalization is on the horizon and jostling into position to capitalize on that possibility.
Hemp plantings in the United States were nearly cut in half in 2022, with 28,400 acres dedicated to growing the plant – slightly more than the acreage set aside for Christmas trees.
It’s been a little more than a year since New Mexico launched adult-use marijuana, with sales topping $300 million during the initial 12 months.
Australia’s medical cannabis industry continues to experience brisk growth in patients and sales, and experts say the market could even surpass Canada’s medical sector this year.
The high cost of medical cannabis poses major obstacles for Canadian patients, even as recreational marijuana prices remain low, a new survey of thousands of Canadians suggests
News of widespread layoffs at cannabis companies across the United States have dominated headlines, but an analysis of employee head counts at America’s largest cannabis companies show several actually grew their payrolls last year.
